首页> 美国卫生研究院文献>Frontiers in Medicine >Severe Dyspnea Is an Independent Predictor of Readmission or Death in COPD Patients Surviving Acute Hypercapnic Respiratory Failure in the ICU
【2h】

Severe Dyspnea Is an Independent Predictor of Readmission or Death in COPD Patients Surviving Acute Hypercapnic Respiratory Failure in the ICU

机译:严重呼吸困难是ICU中急性高碳酸血症性呼吸衰竭幸存的COPD患者再入院或死亡的独立预测因子

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: Predicting outcome after index admission in the ICU for COPD-related acute hypercapnic respiratory failure (AHRF) is difficult. Simple tools to stratify this risk and to promote interventions to mitigate it are needed.>Aim: To prospectively evaluate the ability of severe dyspnea (NYHAIII-IV) to predict hospital readmission or death in COPD patients surviving AHRF in the ICU.>Methods: 50 consecutive COPD patients were recruited from a larger cohort of patients (n = 78) surviving AHRF in the ICU. All predictive variables were collected within 15 days after resolution of respiratory failure before hospital discharge. COPD was diagnosed by spirometry. Heart failure was diagnosed with clinical rules and echocardiography. NYHA was measured upon hospital discharge. Hospital readmission and death were recorded at regular intervals for 3 months.>Results: 21/50 (42%) COPD patients died or were readmitted to the hospital during the observation period: 12 out of the 20 NYHA III-IV patients (60%) and 8 out of the 28 NYHA I-II patients (29%). NYHA III-IV was associated with risk of readmission or death (univariate HR: 2.73, IC95: 1.11–6.69, p = 0.028). After controlling for age, FEV1, heart failure and BMI, NYHA III-IV remained associated with readmission or death (multivariate HR: 2.71, IC95: 1.06–6.93, p = 0.038).>Conclusions: Our findings suggest that severe dyspnea measured upon hospital discharge in COPD patients surviving AHRF can stratify patient's risk of 3-month readmission or death.
机译:>背景:很难预测ICU入院后COPD相关急性高碳酸血症性呼吸衰竭(AHRF)的结局。需要简单的工具来对这种风险进行分层并促进干预措施以减轻这种风险。>目标:前瞻性评估严重呼吸困难(NYHAIII-IV)预测在AHRF中幸存的COPD患者的住院再入院或死亡的能力。 >方法:从ICU中AHRF幸存的较大患者队列(n = 78)中招募了50名连续COPD患者。在出院前解决呼吸衰竭后的15天内收集所有预测变量。通过肺活量测定诊断为COPD。通过临床规则和超声心动图诊断出心力衰竭。 NYHA在出院时进行测量。定期记录住院再入院和死亡情况,为期3个月。>结果::21/50(42%)COPD患者在观察期内死亡或再次入院:20例NYHA III中有12例-IV患者(60%)和28名NYHA I-II患者中的8名(29%)。 NYHA III-IV与再次入院或死亡的风险相关(单变量HR:2.73,IC95:1.11–6.69,p = 0.028)。在控制了年龄,FEV1,心力衰竭和BMI之后,NYHA III-IV仍与再入院或死亡相关(多元HR:2.71,IC95:1.06-6.93,p = 0.038)。>结论:提示在AHRF幸存的COPD患者出院时测得的严重呼吸困难可将患者3个月再入院或死亡的风险分层。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号